Delisting riskPopularity #4,022
Jaguar Health (JAGX)
Develops and supplies crofelemer treatments for intestinal failure and diarrhea in people and animals.
$8.89
vs last close−25.57 (−74.20%)
Something off on this page? Send us feedback.
Next report
Nov 12, 26
in 50 days
EPS estimate
−$614.25
Revenue estimate
$4.9M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Apr '26May '26Aug '26Nov '26
Reported−$2.78−$5.85−$3.59−$2.20−$3.14−$2.04−$2.36Pending
Estimate−$2.78−$3.79−$2.50−$1.78−$1.49−$10.71−$7.82−$614.25
Surprise0.0%−54.3%−43.8%−23.6%−110.6%+81.0%+69.9%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Apr '26May '26Aug '26Nov '26
Reported$3.5M$2.2M$3.0M$3.1M$3.2M$20.3M$1.2MPending
Estimate$3.1M$2.8M$3.3M$3.7M$4.2M$3.7M$4.2M$4.9M
Surprise+12.9%−21.5%−8.9%−17.3%−23.2%+452.4%−71.1%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2026 | −$666.75 | — | — |
| Nov 2026 | −$614.25 | — | — |
| Aug 2026 | −$7.82 | −$2.36 | +69.9% |
| May 2026 | −$10.71 | −$2.04 | +81.0% |
| Apr 2026 | −$1.49 | −$3.14 | −110.6% |
| Nov 2025 | −$1.78 | −$2.20 | −23.6% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Apr 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Apr 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Apr 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2026 | −$666.75 | — | — | $5.5M | — | — | — |
| Nov 12, 2026 | −$614.25 | — | — | $4.9M | — | — | — |
| Aug 19, 2026 | −$7.82 | −$2.36 | +69.9% | $4.2M | $1.2M | −71.1% | −5.5% |
| May 20, 2026 | −$10.71 | −$2.04 | +81.0% | $3.7M | $20.3M | +452.4% | −5.5% |
| Apr 7, 2026 | −$1.49 | −$3.14 | −110.6% | $4.2M | $3.2M | −23.2% | −0.1% |
| Nov 12, 2025 | −$1.78 | −$2.20 | −23.6% | $3.7M | $3.1M | −17.3% | +0.6% |
| Aug 14, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 31, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 14, 2024 | |||||||
| Apr 1, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 24, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 22, 2022 | |||||||
| May 10, 2022 | |||||||
| Mar 11, 2022 | |||||||
| Nov 17, 2021 | |||||||
| Aug 13, 2021 | |||||||
| May 17, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Nov 16, 2020 | |||||||
| Aug 13, 2020 | |||||||
| May 15, 2020 | |||||||
| Apr 3, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Aug 14, 2019 | |||||||
| May 21, 2019 | |||||||
| Apr 10, 2019 | |||||||
| Nov 19, 2018 | |||||||
| Aug 13, 2018 | |||||||
| May 15, 2018 | |||||||
| Apr 9, 2018 | |||||||
| Nov 20, 2017 | |||||||
| Aug 9, 2017 | |||||||
| May 15, 2017 | |||||||
| Feb 15, 2017 | |||||||
| Nov 14, 2016 | |||||||
| Aug 15, 2016 | |||||||
| May 10, 2016 | |||||||
| Mar 29, 2016 | |||||||
| Nov 13, 2015 | |||||||
| Aug 13, 2015 |